TCL Archive New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial May 30, 2014
TCL Archive Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer January 25, 2008
TCL Archive Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall September 15, 1978
TCL Archive In Brief: Appropriations Markup Delayed Until September; FCRC Recompetition Draws 94 Requests for RFP July 31, 1981
TCL Archive Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA. May 16, 2008
